Literature DB >> 4194690

Combined treatment of parkinsonism with L-dopa and amantadine.

R B Godwin-Austen, C C Frears, S Bergmann, J D Parkes, R P Knill-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4194690     DOI： 10.1016/s0140-6736(70)90002-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Augmenting the action of levodopa.

Authors:  S K Rao; S D Vakil; D B Calne; A Hilson
Journal:  Postgrad Med J       Date:  1972-11       Impact factor: 2.401

2.  Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Authors:  N Callagham; M Mcllroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  On the effect of amantadine on ATP content and ATPase activity in brain and blood of rats.

Authors:  V A Velkov
Journal:  Experientia       Date:  1974-04-15

5.  Plasma growth hormone and insulin response to levodopa and amantadine.

Authors:  O Kytömäki; R Nousiainen; A Pekkarinen; U K Rinne; M Viljanen
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

6.  Interactions of L-dopa and amantadine in patients with Parkinsonism.

Authors:  B Cox; G Danta; H Schnieden; G M Yuill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

7.  Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.

Authors:  I J Bak; R Hassler; J S Kim; K Kataoka
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

8.  Treatment for Parkinsonism, other than levodopa.

Authors: 
Journal:  Br Med J       Date:  1972-03-18

9.  Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa.

Authors:  L Rivera-Calimlim
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

10.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.